Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ampac Fine Chemicals (AFC) is a leading custom development and manufacturing organization (CDMO) specializing in the production of active pharmaceutical ingredients (APIs) and advanced intermediates. The company is widely recognized for its expertise in handling energetic chemistries, high-potency APIs (HPAPIs), and controlled substances. AFC operates multiple cGMP-compliant facilities across the United States, providing services from process development through commercial-scale manufacturing. In 2018, the company was acquired by SK Holdings and now operates as a key component of the SK Pharmteco global contract manufacturing platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AFC Enterprises.